Terms: = Germ cell tumor AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Treatment
26 results:
1. Beyond invasive biopsies: using VASARI MRI features to predict grade and molecular parameters in gliomas.
Setyawan NH; Choridah L; Nugroho HA; Malueka RG; Dwianingsih EK
Cancer Imaging; 2024 Jan; 24(1):3. PubMed ID: 38167551
[TBL] [Abstract] [Full Text] [Related]
2. Radiogenomic landscape: Assessment of specific phagocytosis regulators in lower-grade gliomas.
Maimaiti A; Abulaiti A; Tang B; Dilixiati Y; Li X; Yakufu S; Wang Y; Jiang L; Shao H
Exp Biol Med (Maywood); 2023 Dec; 248(23):2289-2303. PubMed ID: 38062999
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy of Nivolumab and Ipilimumab Combined Therapy as a First-Line Therapy for Patients with Advanced Melanoma and the Urgent Need for an Effective Second-Line Therapy for Patients with Wild-Type BRAF in Japan: A Single Center Retrospective Study.
Muto I; Koga H; Doi R; Katayama E; Nakama K; Nakama T
Kurume Med J; 2023 Nov; 69(1.2):75-80. PubMed ID: 37793888
[TBL] [Abstract] [Full Text] [Related]
4. Biologically Interpretable Deep Learning To Predict Response to Immunotherapy In Advanced Melanoma Using Mutations and Copy Number Variations.
Zhang L; Cao L; Li S; Wang L; Song Y; Huang Y; Xu Z; He J; Wang M; Li K
J Immunother; 2023 Jul-Aug 01; 46(6):221-231. PubMed ID: 37220017
[TBL] [Abstract] [Full Text] [Related]
5. Outcomes in surgical management of sinonasal malignancy-A single comprehensive cancer center experience.
Adilbay D; Valero C; Fitzgerald C; Yuan A; Mimica X; Gupta P; Wong RJ; Shah JP; Patel SG; Ganly I; Cohen MA
Head Neck; 2022 Apr; 44(4):933-942. PubMed ID: 35080076
[TBL] [Abstract] [Full Text] [Related]
6. Integrated computational analyses reveal novel insights into the stromal microenvironment of SHH-subtype medulloblastoma.
Landry AP; Samuel N; Spears J; Zador Z
Sci Rep; 2021 Oct; 11(1):20694. PubMed ID: 34667228
[TBL] [Abstract] [Full Text] [Related]
7. Amide proton transfer weighted (APTw) imaging based radiomics allows for the differentiation of gliomas from metastases.
Sartoretti E; Sartoretti T; Wyss M; Reischauer C; van Smoorenburg L; Binkert CA; Sartoretti-Schefer S; Mannil M
Sci Rep; 2021 Mar; 11(1):5506. PubMed ID: 33750899
[TBL] [Abstract] [Full Text] [Related]
8. CD155 on tumor cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8
Braun M; Aguilera AR; Sundarrajan A; Corvino D; Stannard K; Krumeich S; Das I; Lima LG; Meza Guzman LG; Li K; Li R; Salim N; Jorge MV; Ham S; Kelly G; Vari F; Lepletier A; Raghavendra A; Pearson S; Madore J; Jacquelin S; Effern M; Quine B; Koufariotis LT; Casey M; Nakamura K; Seo EY; Hölzel M; Geyer M; Kristiansen G; Taheri T; Ahern E; Hughes BGM; Wilmott JS; Long GV; Scolyer RA; Batstone MD; Landsberg J; Dietrich D; Pop OT; Flatz L; Dougall WC; Veillette A; Nicholson SE; Möller A; Johnston RJ; Martinet L; Smyth MJ; Bald T
Immunity; 2020 Oct; 53(4):805-823.e15. PubMed ID: 33053330
[TBL] [Abstract] [Full Text] [Related]
9. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
[No Abstract] [Full Text] [Related]
10. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.
Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS
Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467
[TBL] [Abstract] [Full Text] [Related]
11. Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic
Vettermann F; Suchorska B; Unterrainer M; Nelwan D; Forbrig R; Ruf V; Wenter V; Kreth FW; Herms J; Bartenstein P; Tonn JC; Albert NL
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2581-2589. PubMed ID: 31410540
[TBL] [Abstract] [Full Text] [Related]
12. The importance of expressing PDCD4 and PDCD5 anti-oncogenes in glioma.
Wang C; Li JK; Li HZ; Gong HD
J Biol Regul Homeost Agents; 2018; 32(3):731-736. PubMed ID: 29921407
[TBL] [Abstract] [Full Text] [Related]
13. C-Cbl and Cbl-b expression in skull base chordomas is associated with tumor progression and poor prognosis.
Luo P; Wang X; Zhou J; Li L; Jing Z
Hum Pathol; 2018 Apr; 74():129-134. PubMed ID: 29317233
[TBL] [Abstract] [Full Text] [Related]
14. Predictive factors of relapse in low-risk gestational trophoblastic neoplasia patients successfully treated with methotrexate alone.
Couder F; Massardier J; You B; Abbas F; Hajri T; Lotz JP; Schott AM; Golfier F
Am J Obstet Gynecol; 2016 Jul; 215(1):80.e1-7. PubMed ID: 26829503
[TBL] [Abstract] [Full Text] [Related]
15. Genome-wide DNA methylation profiling of recurrent and non-recurrent chordomas.
Alholle A; Brini AT; Bauer J; Gharanei S; Niada S; Slater A; Gentle D; Maher ER; Jeys L; Grimer R; Sumathi VP; Latif F
Epigenetics; 2015; 10(3):213-20. PubMed ID: 25621392
[TBL] [Abstract] [Full Text] [Related]
16. Identification of melanoma biomarkers based on network modules by integrating the human signaling network with microarrays.
Huang C; Sheng Y; Jia J; Chen L
J Cancer Res Ther; 2014 Nov; 10 Suppl():C114-24. PubMed ID: 25450268
[TBL] [Abstract] [Full Text] [Related]
17. treatment of Merkel cell carcinoma of the head and neck: a systematic review.
Raju S; Vazirnia A; Totri C; Hata TR
Dermatol Surg; 2014 Dec; 40(12):1273-83. PubMed ID: 25350122
[TBL] [Abstract] [Full Text] [Related]
18. Association between DNA methylation and multidrug resistance in human glioma SHG-44 cells.
Chen J; Xu ZY; Wang F
Mol Med Rep; 2015 Jan; 11(1):43-52. PubMed ID: 25333456
[TBL] [Abstract] [Full Text] [Related]
19. [Complications after therapeutic dissection of the neck in the treatment of differentiated thyroid gland cancer].
Palamarchuk VA
Klin Khir; 2014 Jan; (1):28-31. PubMed ID: 24923146
[TBL] [Abstract] [Full Text] [Related]
20. Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study.
Larkin J; Del Vecchio M; Ascierto PA; Krajsova I; Schachter J; Neyns B; Espinosa E; Garbe C; Sileni VC; Gogas H; Miller WH; Mandalà M; Hospers GA; Arance A; Queirolo P; Hauschild A; Brown MP; Mitchell L; Veronese L; Blank CU
Lancet Oncol; 2014 Apr; 15(4):436-44. PubMed ID: 24582505
[TBL] [Abstract] [Full Text] [Related]
[Next]
